30-day and 365-day incidences shown for the combined endpoint MACE with its single components, and for the secondary endpoint, all-cause mortality
| . | 30-day incidence (95% CI) . | 365-day incidence (95% CI) . |
|---|---|---|
| Combined endpoint MACE | 15.2% (13.8–16.8) (344/2265) | 20.6% (19.0–22.3) (466/2265) |
| Cardiovascular death | 1.2% (0.9–1.8) (28/2265) | 3.7% (3.0–4.5) (83/2265) |
| Haemodynamically-relevant arrhythmias | 1.2% (0.9–1.8) (28/2265) | 2.1% (1.6–2.8) (47/2265) |
| Acute heart failure | 1.6% (1.2–2.2) (36/2265) | 4.2% (3.4–5.1) (95/2265) |
| Perioperative myocardial infarction/injurya | 13.2% (11.9–14.7) (300/2265) | 14.8% (13.4–16.4) (336/2265) |
| Spontaneous myocardial infarction | 0.5% (0.3–0.9) (12/2265) | 1.6% (1.2–2.2) (37/2265) |
| Secondary endpoint | ||
| All-cause mortality | 3.0% (2.3–3.7) (67/2265) | 11.5% (10.3–12.9) (261/2265) |
| . | 30-day incidence (95% CI) . | 365-day incidence (95% CI) . |
|---|---|---|
| Combined endpoint MACE | 15.2% (13.8–16.8) (344/2265) | 20.6% (19.0–22.3) (466/2265) |
| Cardiovascular death | 1.2% (0.9–1.8) (28/2265) | 3.7% (3.0–4.5) (83/2265) |
| Haemodynamically-relevant arrhythmias | 1.2% (0.9–1.8) (28/2265) | 2.1% (1.6–2.8) (47/2265) |
| Acute heart failure | 1.6% (1.2–2.2) (36/2265) | 4.2% (3.4–5.1) (95/2265) |
| Perioperative myocardial infarction/injurya | 13.2% (11.9–14.7) (300/2265) | 14.8% (13.4–16.4) (336/2265) |
| Spontaneous myocardial infarction | 0.5% (0.3–0.9) (12/2265) | 1.6% (1.2–2.2) (37/2265) |
| Secondary endpoint | ||
| All-cause mortality | 3.0% (2.3–3.7) (67/2265) | 11.5% (10.3–12.9) (261/2265) |
Data are presented as percentage (95% confidence interval), in brackets () absolute number/total number of patients.
CI, confidence interval; MACE, major adverse cardiac events.
Initial PMI and PMI occurring during subsequent surgical procedures within 365 days of follow-up.
30-day and 365-day incidences shown for the combined endpoint MACE with its single components, and for the secondary endpoint, all-cause mortality
| . | 30-day incidence (95% CI) . | 365-day incidence (95% CI) . |
|---|---|---|
| Combined endpoint MACE | 15.2% (13.8–16.8) (344/2265) | 20.6% (19.0–22.3) (466/2265) |
| Cardiovascular death | 1.2% (0.9–1.8) (28/2265) | 3.7% (3.0–4.5) (83/2265) |
| Haemodynamically-relevant arrhythmias | 1.2% (0.9–1.8) (28/2265) | 2.1% (1.6–2.8) (47/2265) |
| Acute heart failure | 1.6% (1.2–2.2) (36/2265) | 4.2% (3.4–5.1) (95/2265) |
| Perioperative myocardial infarction/injurya | 13.2% (11.9–14.7) (300/2265) | 14.8% (13.4–16.4) (336/2265) |
| Spontaneous myocardial infarction | 0.5% (0.3–0.9) (12/2265) | 1.6% (1.2–2.2) (37/2265) |
| Secondary endpoint | ||
| All-cause mortality | 3.0% (2.3–3.7) (67/2265) | 11.5% (10.3–12.9) (261/2265) |
| . | 30-day incidence (95% CI) . | 365-day incidence (95% CI) . |
|---|---|---|
| Combined endpoint MACE | 15.2% (13.8–16.8) (344/2265) | 20.6% (19.0–22.3) (466/2265) |
| Cardiovascular death | 1.2% (0.9–1.8) (28/2265) | 3.7% (3.0–4.5) (83/2265) |
| Haemodynamically-relevant arrhythmias | 1.2% (0.9–1.8) (28/2265) | 2.1% (1.6–2.8) (47/2265) |
| Acute heart failure | 1.6% (1.2–2.2) (36/2265) | 4.2% (3.4–5.1) (95/2265) |
| Perioperative myocardial infarction/injurya | 13.2% (11.9–14.7) (300/2265) | 14.8% (13.4–16.4) (336/2265) |
| Spontaneous myocardial infarction | 0.5% (0.3–0.9) (12/2265) | 1.6% (1.2–2.2) (37/2265) |
| Secondary endpoint | ||
| All-cause mortality | 3.0% (2.3–3.7) (67/2265) | 11.5% (10.3–12.9) (261/2265) |
Data are presented as percentage (95% confidence interval), in brackets () absolute number/total number of patients.
CI, confidence interval; MACE, major adverse cardiac events.
Initial PMI and PMI occurring during subsequent surgical procedures within 365 days of follow-up.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
